Oyen W - Search Results

1

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.

Fanti S, Minozzi S, Castellucci P, Balduzzi S, Herrmann K, Krause BJ, Oyen W, Chiti A. Fanti S, et al. Among authors: oyen w. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):55-69. doi: 10.1007/s00259-015-3202-7. Epub 2015 Oct 9. Eur J Nucl Med Mol Imaging. 2016. PMID: 26450693 Review.

2

The uptake mechanisms of inflammation- and infection-localizing agents.

Oyen WJ, Boerman OC, van der Laken CJ, Claessens RA, van der Meer JW, Corstens FH. Oyen WJ, et al. Eur J Nucl Med. 1996 Apr;23(4):459-65. doi: 10.1007/BF01247377. Eur J Nucl Med. 1996. PMID: 8612669 Review.

3

Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.

Drenth JP, Nagengast FM, Oyen WJ. Drenth JP, et al. Among authors: oyen wj. Eur J Nucl Med. 2001 Dec;28(12):1766-9. doi: 10.1007/s002590100645. Epub 2001 Oct 19. Eur J Nucl Med. 2001. PMID: 11734913

4

Fluorinated amino acids for tumour imaging with positron emission tomography.

Laverman P, Boerman OC, Corstens FH, Oyen WJ. Laverman P, et al. Eur J Nucl Med Mol Imaging. 2002 May;29(5):681-90. doi: 10.1007/s00259-001-0716-y. Epub 2002 Jan 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976809 Review.

5

PET-CT: a matter of opinion?

Jager PL, Slart RH, Corstens F, Oyen WJ, Hoekstra O, Teule J. Jager PL, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):470-1; author reply 471. doi: 10.1007/s00259-002-1081-1. Epub 2003 Jan 8. Eur J Nucl Med Mol Imaging. 2003. PMID: 12634973 No abstract available.

6

Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.

Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Bleeker-Rovers CP, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):29-37. doi: 10.1007/s00259-003-1338-3. Epub 2003 Oct 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14551752

7

FDG-PET in infectious and inflammatory disease.

Oyen WJ, Mansi L. Oyen WJ, et al. Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1568-70. doi: 10.1007/s00259-003-1359-y. Epub 2003 Oct 2. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579098 No abstract available.

8

FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.

van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP. van Kouwen MC, et al. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):399-404. doi: 10.1007/s00259-004-1689-4. Epub 2004 Nov 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15549297 Clinical Trial.

9

Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.

de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. de Groot M, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):98-101. doi: 10.1007/s00259-004-1670-2. Epub 2004 Oct 5. Eur J Nucl Med Mol Imaging. 2005. PMID: 15605289

10

Accuracy of rigid CT-FDG-PET image registration of the liver.

van Dalen JA, Vogel W, Huisman HJ, Oyen WJ, Jager GJ, Karssemeijer N. van Dalen JA, et al. Among authors: oyen wj. Phys Med Biol. 2004 Dec 7;49(23):5393-405. doi: 10.1088/0031-9155/49/23/014. Phys Med Biol. 2004. PMID: 15656285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

692 results

Search Page